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Edited by Michael R. BubbAbstract Stimulation of Dictyostelium cells with the chemoat-
tractant cAMP results in transient phosphorylation of the myo-
sin regulatory light chain (RLC). We show that myosin light
chain kinase A (MLCK-A) is responsible for RLC phosphoryla-
tion during chemotaxis, and that MLCK-A itself is transiently
phosphorylated on threonine-166, dramatically increasing its
catalytic activity. MLCK-A activation during chemotaxis is
highly responsive to cellular cGMP levels and the cGMP-binding
protein GbpC. MLCK-A cells have a partial cytokinesis defect,
and do not phosphorylate RLC in response to concanavalin A
(conA), but cells lacking cGMP or GbpC divide normally and
phosphorylate in response to conA. Thus MLCK-A is activated
by a cGMP/GbpC-independent mechanism activated during
cytokinesis or by conA, and a cGMP/GbpC-dependent pathway
during chemotaxis.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Dictyostelium; Chemotaxis; cGMP; Myosin;
Regulatory light chain; Phosphorylation1. Introduction
Motile cells such as Dictyostelium respond to chemoattrac-
tant gradients by adopting a polarized morphology, allowing
them to move up the gradient. Under starvation conditions,
Dictyostelium cells both secrete and move toward cAMP,
thereby using cAMP chemotaxis to form aggregates of cells.
As a simple eukaryote with a highly developed chemotactic re-
sponse, Dictyostelium is an ideal model system for elucidating
the signaling pathways and cytoskeletal rearrangements
responsible for chemotaxis [1].
The protrusive force for migration in eukaryotic cells comes
from actin polymerization at the leading edge of the cell. Pio-
neering work in Dictyostelium has shown that myosin II, ﬁrst
described as the motor responsible for muscle contraction, also
contributes to motility during chemotaxis [2]. Myosin is local-
ized to the rear of polarized cells in a cAMP gradient [3], where
it probably suppresses pseudopod formation and promotes
retraction of the rear of the cell [4,5].*Corresponding author. Fax: +1 617 972 1761.
E-mail address: smith@bbri.org (J.L. Smith).
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(RLC) are transiently phosphorylated after stimulation with
extracellular cAMP, and there is a transient increase in myosin
association with the cytoskeleton [6,7]. RLC phosphorylation
increases the motility and actin-activated ATPase activity of
myosin [8]. Cells expressing a mutant RLC with alanine at the
phosphorylation site (‘‘S13A cells’’) form fewer lateral pseudo-
pods during chemotaxis, and do not lose their polarity at the
peak concentration of a cAMP wave as wild-type cells do, indi-
cating that RLC phosphorylation contributes to chemotaxis [9].
Chemotaxis is accompanied by a transient increase in intra-
cellular cGMP levels [10,11], and cells unable to synthesize
cGMP have a reduced RLC phosphorylation response to
cAMP, as do cells lacking GbpC, a complex cGMP-binding
protein containing ras, protein kinase, and rasGEF domains
[12–14]. These studies indicate that cGMP and GbpC play ma-
jor roles in RLC phosphorylation during chemotaxis. Cells
lacking cGMP and GbpC have additional defects in myosin
heavy chain phosphorylation and myosin assembly, and
chemotax very poorly [13].
RLC is phosphorylated by myosin light chain kinase A
(MLCK-A) and one or more other kinases that have not yet
been identiﬁed [15]. MLCK-A is, respectively, activated
approximately 7- and 200-fold by phosphorylation of threo-
nine-289 near its C-terminus and threonine-166 in its activa-
tion loop ([16–18] and J.S., unpublished results). Unlike its
well-known namesakes in the MLCK family of kinases,
MLCK-A, a CAMK1 family member, is not regulated by
Ca2+/calmodulin binding. MLCK-A is phosphorylated in re-
sponse to cGMP addition in crude lysates, and by treatment
of vegetative cells with conA [15,16]. MLCK-A knock-outs
also have a partial defect in cytokinesis, suggesting that
MLCK-A is activated during cytokinesis, as well [15]. Here
we show that MLCK-A is solely responsible for RLC phos-
phorylation during chemotaxis, and that at least two signaling
pathways are responsible for MLCK-A activation: a cGMP/
GbpC-independent pathway that is activated by conA treat-
ment and during cytokinesis, and a cGMP/GbpC-dependent
pathway that predominates during chemotaxis.2. Materials and methods
2.1. In vivo phosphorylation of RLC and MLCK-A
Starved cells were pulsed with cAMP, treated with caﬀeine, labeled
with 32P[Pi], and stimulated with cAMP and DTT as described [13], ex-
cept that typically 60 nM cAMP pulses were used. RLC and MLCK-Ablished by Elsevier B.V. All rights reserved.
Fig. 1. MLCK-A is required for RLC phosphorylation during
chemotaxis, and is activated by threonine-166 phosphorylation. Cells
32
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quantitated using a BioRad GS-505 Molecular Imager System. The
myosin heavy chain was coimmunoprecipitated, and its intensity on
coommasie stained gels was used to verify equal loading over the time
courses. RLC phosphorylation after conA treatment was determined
using urea glycerol gels as described previously [16].
2.2. Cyclic GMP levels during conA treatment
Cells were harvested and washed in 20 mM 2-(Nmorpholino)
ethanesulfonic acid-KOH, pH 6.8, 2 mM MgCl2, and resuspended at
2 · 108 cells/ml. Air was bubbled through the cell suspension for
10 min, conA was added to 75 lg/ml, and cGMP levels were measured
as described [13].
2.3. gbpC gene disruption
A genomic PCR product spanning codons 1855–2048 of gbpC
(579 bp) was inserted into the XbaI/BamHI sites of pBsrDBamHI
(kindly provided by Dr. Kazoh Sutoh), and a second genomic PCR
product corresponding to codons 749–1002 (759 bp) was inserted into
the HindIII site. In the resulting plasmid, 2.6 kb of the gbpC gene are
replaced with the 1.3 kb Bsr cassette, with the Bsr and gbpC open read-
ing frames are on opposite strands. The insert of this plasmid (pJS84)
was ampliﬁed by PCR, gel puriﬁed, and 3 lg was electroporated into
JH10 cells [19]. Colonies were selected using 5 lg/ml blasticidin (Invit-
rogen). Genomic DNA was isolated from resistant colonies using
DNAzol (Invitrogen), and used to screen candidates by PCR. Addi-
tional DNA for Southern blotting was isolated as described [20].
2.4. Dictyostelium plasmids and cell lines
Extrachromosomal plasmids expressing MLCK-AT166A and
MLCK-AT289A have been described [17]. The mlkA line in JH10 cells,
and the gca/sgc, gbpA/gbpB and gbpC lines in DH1 cells have
also been described [13,15,21].were labeled with [ P]orthophosphate, and RLC and MLCK-A were
immunoprecipitated from aliquots at the indicated times (in seconds)
before and after stimulation with cAMP. (A) RLC phosphorylation in
the wild-type strain (JH10), MLCK-A null cells (mlkA), and mlkA
cells overexpressing MLCK-AT289A and MLCK-AT166A. Gels for JH10
and mlkA are representative of four independent experiments, and
gels for MLCK-AT289A and MLCK-AT166A are representative of two
independent experiments. (B) RLC phosphorylation was quantitated
by phosphorimaging gels such as those presented in Part A, and the
ratio of 32P incorporation at 60 and 15 s is plotted. Error bars
indicate the S.D. obtained from averaging two or more data sets. The
statistical signiﬁcance that the maximal response in the mutant strains
diﬀers from wild-type was tested with Students t test. For mlkA,
P = 0.05; T289A, P = 0.49 (not signiﬁcant); T166A, P = 0.13. (C)
MLCK-A phosphorylation in JH10, and mlkA cells overexpressing
MLCK-AT166A or MLCK-AT289A. For JH10, data is representative of
four independent experiments, and for the MLCK-AT166A and
MLCK-AT289A overexpressors, similar results were obtained in two
independent experiments. All exposures for panels A and B were for
24 h, using BioMax MS ﬁlm (Kodak) and one intensifying screen.3. Results
3.1. MLCK-A is responsible for RLC phosphorylation during
chemotaxis
We used metabolic labeling to examine RLC phosphoryla-
tion after chemotactic stimulation in wild-type and MLCK-
A null (mlkA) cells to determine whether MLCK-A is the ki-
nase responsible for RLC phosphorylation during chemotaxis.
In the JH10 parental strain, RLC phosphorylation increased
dramatically after stimulation with cAMP, with a maximum
at approximately 60 s, whereas RLC phosphorylation in
MLCK-A nulls did not (Fig. 1A and B). Thus MLCK-A is
the only kinase responsible for the chemoattractant-elicited in-
crease in RLC phosphorylation. The basal level of RLC phos-
phorylation seen in the MLCK-A nulls is due to an additional
MLCK activity that has not been identiﬁed.
MLCK-A is itself transiently phosphorylated during chemo-
taxis, with a maximum 20 s after stimulation (Fig. 1C). We
expressed MLCK-AT166A and MLCK-AT289A in mlkA cells
in order to determine which site is phosphorylated in response
to cAMP. Phosphorylation of MLCK-AT289A increased
dramatically, while phosphorylation of MLCK-AT166A in-
creased only slightly (Fig. 1C), indicating that chemotactic
stimulation results in phosphorylation primarily of threo-
nine-166. RLC phosphorylation levels in cells expressing
MLCK-AT166A are greatly reduced (Fig. 1A and B), indicating
that phosphorylation at threonine-166 is necessary for robust
RLC phosphorylation. The fold increase in RLC phosphoryla-
tion in MLCK-AT289A cells is indistinguishable from wild-
type, within experimental error (Fig. 1B). The higher basal
level of RLC phosphorylation in these cells is probably dueto the fact that the mutant MLCK-A proteins are overexpres-
sed 10-fold (data not shown). Overexpression probably also
serves to magnify the small increase in RLC phosphorylation
that is observed in MLCK-AT166A cells. We also examined
whether recruitment of MLCK-A to the cell cortex might pro-
vide an additional activation mechanism. MLCK-A remained
diﬀusely localized in the cytosol after cAMP stimulation, sug-
gesting that a change in localization does not contribute to
MLCK-A’s activation (data not shown).
3.2. MLCK-A is activated by cGMP and GbpC during
chemotaxis
In Dictyostelium cGMP is synthesized by two guanylyl cyc-
lases, encoded by gca and sgc genes, and in gca/sgc cells, no
detectable cGMP is present [21–23]. In these cells, a smaller in-
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tion with cAMP compared with the DH1 parental strain
(Fig. 2). Thus MLCK-A phosphorylation is mostly, but not
exclusively, dependent on cGMP. Cells lacking the phosphodi-
esterases GbpA and GbpB have elevated basal and stimulated
levels of cGMP, and stimulated levels do not return to baseline
until 3–4 min compared with 30 s for wild-type cells [13]. In
gbpA/gbpB cells, MLCK-A phosphorylation is sustained
and slightly elevated compared to wild-type cells, suggesting
that sustained cGMP levels results in sustained MLCK-A acti-
vation (Fig. 2).
GbpC is implicated in mediating the eﬀects of cGMP in re-
sponse to chemoattractants, and experiments on a gbpC gene
disruption strain engineered in DH1 cells point to a key role
for this protein in myosin regulation during chemotaxis
[12,13]. In order to evaluate the role of GbpC in MLCK-A
activation, we disrupted the genomic gbpC locus in JH10 cells,
since this is the genetic background used for our other studies
on MLCK-A. The gbpC gene was disrupted using the homol-
ogous recombination strategy summarized in Fig. 3. In a PCR
screen, 15/15 transformants had a disrupted gbpC locus. Seven
gave a PCR product of the expected size, but the rest gave a
product that was 0.3 kb smaller than expected, and were
not further characterized. Southern blotting was used to con-
ﬁrm that the disrupted gbpC genomic locus had the predicted
structure, and that the construct had not integrated into a sec-
ondary site (Fig. 3B), and cGMP-binding assays on lysatesFig. 2. Cyclic GMP and GbpC promote MLCK-A activation in vivo.
(A) MLCK-A was immunoprecipitated from aliquots of 32P-labeled
cultures at the indicated times before and after stimulation with
cAMP. Incorporation of 32P into MLCK-A was visualized by
autoradiography of SDS gels. All gels were exposed to BioMax MS
ﬁlm (Kodak) for 24 h, using one intensifying screen. (B) MLCK-A
phosphorylation was quantitated by phosphorimaging gels such as
those presented in Part A. The ratio of 32P incorporation at the
maximum time point (20–30 s for all cell lines except gbpA/gbpB)
and at 15 s is plotted. Error bars indicate the S.D. obtained from
averaging at least two data sets. The statistical signiﬁcance that the
maximal response in the mutant strains diﬀers from wild-type was
tested with Students t test. For gc, P = 0.07; A/B, P = 0.34 (not
signiﬁcant); C (DH1 background), P = 0.20; C (JH10 background),
P = 0.04.from the gbpC cells conﬁrmed that the protein is gone (data
not shown). During development, these cells formed aggre-
gates and fruiting bodies that were approximately half the size
of wild-type (Fig. 3C). This is consistent with a severe defect in
chemotaxis to cAMP, as has been characterized in detail for
gbpC cells isolated in the DH1 parental strain [13].
In metabolic labeling experiments using JH10 cells, cAMP
stimulation resulted in MLCK-A phosphorylation levels that
were 10.2-fold higher than those before stimulation, compared
with 3.1-fold higher in gbpC cells isolated in the JH10 back-
ground (Fig. 2). In parallel experiments in the DH1 back-
ground, a comparable eﬀect of a gbpC gene disruption was
observed (Fig. 2), although for unknown reasons the
MLCK-A phosphorylation response was much more dramatic
in JH10 than in DH1 cells. The decreases in MLCK-A phos-
phorylation that we observe in cell lines lacking cGMP and
GbpC correlate with decreases in RLC phosphorylation in
these strains ([13]; JLS, unpublished results). Thus GbpC is
needed for the full MLCK-A and RLC phosphorylation re-
sponses.
3.3. GbpC and cGMP do not play a role in cytokinesis
Since GbpC is implicated in myosin II regulation during che-
motaxis it might also be involved in the regulation of myosin
during cytokinesis. Myosin II is essential for cytokinesis in sus-
pension cultures; in cells lacking functional myosin, an accu-
mulation of large, multinucleate cells, rather than an increase
in cell number, is observed [24,25]. We found that growth rates
in axenic media for the two gbpC cell lines were indistinguish-
able from their parental strains, indicating that gbpC cells are
able to divide in suspension (data not shown). Using DAPI
staining to visualize the nuclei, no increase in multinucleate
cells was observed in either gbpC strain, or in scg/gca cells
(Fig. 3D). Thus, cGMP and GbpC appear to be dispensable
for cytokinesis.
3.4. ConA-activation of MLCK-A is not mediated by cGMP or
GbpC
In light of our ﬁndings that MLCK-A is activated by cGMP
and GbpC during chemotaxis, we investigated whether this
same pathway activates MLCK-A after conA treatment. We
found that cGMP levels remain essentially unchanged after
conA treatment of cells (Fig. 4A). We used gca/sgc cells to
evaluate whether basal levels of cGMP might be needed for
RLC phosphorylation after conA treatment. For wild-type
cells approximately half of the RLC is phosphorylated prior
to conA treatment, and increases to 100% or nearly 100% after
treatment (Fig. 4B, see also [15,16]). In gca/sgc cells, quan-
titative phosphorylation of RLC is observed after conA treat-
ment indicating that cGMP is not required for the response,
and GbpC was also found to not be required (Fig. 4B).4. Discussion
In order to understand signaling pathways and myosin reg-
ulation during chemotaxis, it is important to know whether
RLC phosphorylation involves MLCK-A, another MLCK
(which is present but has not been identiﬁed), or a combination
of enzymes. Here we show that MLCK-A is solely responsible
for RLC phosphorylation during chemotaxis, and that
Fig. 3. Gene disruption of gbpC. (A) The strategy for disrupting gbpC in the parental strain JH10 using a construct that replaces an internal portion
of gbpC with a cassette encoding blasticidin resistance (Bsr). The primers used in the PCR screen are indicated as convergent arrows. The domains in
GbpC are abbreviated as follows: LRR, leucine rich repeats; Ras, raslike domain; kinase, protein kinase domain; RasGEF, N-terminal Ras guanine
nucleotide exchange factor domain; DEP, domain found in dishevelled, Egl-10, and pleckstrin; cG, cGMP-binding domain; GRAM, domain found
in glucosyltransferases, Rab-like GTPase activators, and myotubularins. (B) Southern blot conﬁrming the structure of the disrupted gbpC locus, and
demonstrating that the construct did not insert into secondary sites. DNA from the parental strain (lanes 1 and 3) and the gene disruption strain
(lanes 2 and 4) was digested with HpaII and probed with Bsr (probe #1, lanes 1 and 2) or a portion of gbpC which is retained in the disrupted locus
(probe #2, lanes 3 and 4). These probe fragments are indicated in Part A. (C) Wild-type (JH10) and gbpC cells were developed on black HA ﬁlters as
described [28], and photographed at identical magniﬁcation. (D) The number of nuclei per cell was determined by DAPI staining of cells that had
been grown and ﬁxed in suspension. White bars, JH10 cells; dark grey bars, gbpC in JH10 background; striped bars, DH1; black bars, gbpC in
DH1 background; light grey bars, gca/sgc in DH1 background.
Fig. 4. Activation of MLCK-A by conA treatment is GbpC/cGMP-
independent. (A) Cellular cGMP levels were measured in the wild-type
strain Ax3. Data points are the average of three independent
measurements, and the error bars indicate the S.D. (B) In vivo
changes in RLC phosphorylation in vegetatively growing cells after
mock-treatment with buﬀer or after conA treatment (lanes marked
‘‘’’ and ‘‘+’’, respectively) were determined by running whole cell
lysates on urea-glycerol gels. The RLC was visualized by immuno-
blotting, and the positions of unphosphorylated and phosphorylated
forms are indicated.
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with an increase in phosphorylation of the activation-loop res-
idue threonine-166, which dramatically increases the enzymatic
activity of MLCK-A [17].
We also show that maximal phosphorylation (and hence
activation) of MLCK-A depends on GbpC, and is highlyresponsive to cellular cGMP levels. The role of GbpC and
cGMP in MLCKA activation essentially parallels our previous
ﬁndings that cGMP and GbpC promote RLC phosphoryla-
tion during chemotaxis [13], and allows us to formulate a rel-
atively complete model of the signaling pathway resulting in
RLC phosphorylation during chemotaxis (Fig. 5). Chemoat-
tractants lead to the activation of guanylyl cyclases, resulting
in an increase in intracellular cGMP levels. GbpC, which binds
cGMP with high aﬃnity [12], is activated by this increase in
cGMP levels. GbpC, in turn, either phosphorylates MLCK-
A on threonine-166, or activates another protein kinase that
does so, and the resulting increase in MLCK-A activity leads
to a robust increase in RLC phosphorylation [16].
By contrast, we show here that MLCK-A activation in re-
sponse to conA is not the result of cGMP signaling and GbpC.
We also found that a small amount of MLCK-A activation
during chemotaxis is cGMP/GbpC-independent. An economi-
cal model consistent with our data is that the cGMP/GbpC-
independent pathway responsible for the conA response is
the same as the cGMP/GbpC-independent pathway that plays
a minor role during chemotaxis (Fig. 5).
An increase in RLC phosphorylation during cytokinesis has
been observed in several studies using mammalian tissue cul-
ture cells [26], supporting a role for myosin II as a molecular
motor in the contractile ring during this process. MLCK-A
nulls have a partial defect in cytokinesis [15], suggesting it is
activating during cytokinesis. This would result in an increase
in RLC phosphorylation during cytokinesis, as in mammalian
cells. Surprisingly, the cytokinesis defect observed in MLCK-A
nulls is not shared by S13A cells, which harbor a non-phos-
Fig. 5. Model for the signaling pathways controlling RLC phosphor-
ylation. RLC phosphorylation in Dictyostelium is carried out by
MLCK-A and one or more additional kinases, represented as
‘‘other(s)’’ in the cartoon. According to the model, the other kinase(s)
only contributes to constitutive RLC phosphorylation. Weakly acti-
vated pathways are indicated by a dotted arrow, and stronger pathways
by a solid arrow. ConA and cAMP binding to receptors on the cell
surface lead to MLCK-A activation and RLC phosphorylation by
pathways indicated. Cytokinesis may also lead to MLCK-A activation
by the cGMP/GbpC-independent pathway, but since the evidence for
this pathway is indirect, it is marked with a question mark.
J.M. Goldberg et al. / FEBS Letters 580 (2006) 2059–2064 2063phorylatable RLC [27], indicating that MLCK-A may have
additional important substrates during cytokinesis. Since
gbpC and gca/sgc cells do not appear to have a cytokinesis
defect, the pathway activating MLCK-A during cytokinesis is
most likely cGMP/GbpC-independent. Indeed, gbpC mRNA
levels increase dramatically by 8 h of development [12], provid-
ing additional support for our model that GbpC plays a major
role in cAMP chemotaxis, but little or no role during cytokine-
sis or in response to conA treatment, both processes of the veg-
etative cell.
The present study has demonstrated a decisive link between
cGMP, GbpC, MLCK-A activation, and RLC phosphoryla-
tion during chemotaxis. It also provides evidence for a
cGMP/GbpC-independent pathway that is involved in conA
capping, plays a minor role during chemotaxis, and may also
be activated during cytokinesis. Further studies aimed at iden-
tifying the components of this cGMP/GbpC-independent
pathway may provide valuable insights into each of these pro-
cesses.
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